N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
US6919332B2 · kind B2 · utility
83Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2003 |
| Grant date | Jul 19, 2005 |
| Priority date | — |
| Expiry date | Apr 28, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to N-substituted-heteroaryloxy-aryloxy-2,4,6-trione metalloproteinase inhibitors of the formula wherein X, A, Y, B, G, and R1 are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.